The Importance of <i>STK11</i>/<i>LKB1</i> Assessment in Non-Small Cell Lung Carcinomas

Despite the recent implementation of immunotherapy as a single treatment or in combination with chemotherapy for first-line treatment of advanced non-small cell lung cancer (NSCLC), many patients do not benefit from this regimen due to primary treatment resistance or toxicity. Consequently, there is...

Full description

Bibliographic Details
Main Authors: Baharia Mograbi, Simon Heeke, Paul Hofman
Format: Article
Published: MDPI AG 2021-01-01
Online Access: